Planner and Faculty Disclosure Information
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established conflict-of-interest resolution process and have stated that these reported relationships will not have any impact on their ability to provide unbiased content.
Planners:
Ira M. Cheifetz, MD, FCCM
Rainbow Babies and Children’s Hospital
Cleveland, Ohio, USA
Medtronic – medical advisor; Up-to-date - contributor
Ana Lia Graciano, MD, FCCM
University of Maryland
Baltimore, Maryland, USA
No relevant financial relationships to disclose
Ravi Thiagarajan, MD
Boston Children’s Hospital
Boston, Massachusetts, USA
Bristol Myers Squibb and Pfizer - member event adjudication committee for clinical trial
Theresa Woike
Society of Critical Care Medicine
Mount Prospect, Illinois, USA
No relevant financial relationships to disclose
Faculty:
Asya Agulnik, MD
St. Jude Children’s Research Hospital
Memphis, Tennessee, USA
No relevant financial relationships to disclose
Alicia M. Alcamo, MD, MPH
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, USA
No relevant financial relationships to disclose
Raj Aneja, MD, FCCM
Children’s Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, USA
No relevant financial relationships to disclose
Edward E. Conway Jr, MD, MS, FCCM
Jacobi Medical Center
Bronx, New York, USA
No relevant financial relationships to disclose
Dennis Daniel, MD
Boston Children’s Hospital
Milton, Massachusetts, USA
No relevant financial relationships to disclose
Leslie Dervan, MD
Seattle Children’s Hospital
Seattle, Washington, USA
No relevant financial relationships to disclose
Michael W. Dingeldein, MD
Rainbow Babies and Children’s Hospital
Cleveland, Ohio, USA
No relevant financial relationships to disclose
Allan Doctor, MD
University of Maryland Medical Center
Baltimore, Maryland, USA
Consulting – Viasys, iNO Therapeutics; Galera Pharmaceuticals, Nitrox~N30Pharma; Novartis, Biogen; Research Funding – NIGMS, NHLBI, DoD CDMRP, American Heart Association, Doris Due Foundation, Children’s Discovery Institute, Terumo, BCT and Entergion; Founder/Owner – KaloCyte, Inc
Nicholas A. Ettinger, MD, PhD, FAAP
Texas Children’s Hospital
Houston, Texas, USA
No relevant financial relationships to disclose
Robinder G. Khemani, MD
Children’s Hospital Los Angeles
Los Angeles, California, USA
Nihon Kohden Orangemed – medical advisor
Sapna R. Kudchadkar, MD, PhD
Johns Hopkins University Hospital
Baltimore, Maryland, USA
No relevant financial relationships to disclose
Ryan W. Morgan, MD, MTR
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, USA
No relevant financial relationships to disclose
Jennifer Muszynski, MD, FCCM
Nationwide Children’s Hospital
Columbus, Ohio, USA
No relevant financial relationships to disclose
Gideon Stitt, PharmD, BCPPS, BCCCP
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, USA
No relevant financial relationships to disclose
Katri V. Typpo, MD, MPH
University of Arizona College of Medicine
Tucson, Arizona, USA
Leading Biosciences – consulting services
Henry Michael Ushay, MD, PhD, FCCM
Children’s Hospital at Montefiore
Bronx, New York, USA
No relevant financial relationships to disclose
Scott L. Weiss, MD, MSCE, FCCM
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, USA
No relevant financial relationships to disclose
Janice L. Zimmerman, MD, MCCM
Houston, Texas, USA
No relevant financial relationships to disclose
Jerry J. Zimmerman, MD, PhD, FCCM
Seattle Children’s Hospital
Seattle, Washington, USA
No relevant financial relationships to disclose